Recent Updates
Recently added Catalysts
MAZE Positive Sentiment Score: 70/100

Maze Therapeutics to Participate in the 3rd Annual H.C. Wainwright BioConnect Investor Conference

Tuesday, May 13, 2025 1 min read
Key Takeaway: Maze Therapeutics, a clinical-stage biopharmaceutical company, will participate in the 3rd Annual H.C. Wainwright BioConnect Investor Conference on May 20, 2025. CEO Jason Coloma, Ph.D., will present an overview of the company and engage in one-on-one meetings. The presentation will be accessible on the company's website, with an archived replay available for 60 days. This participation reflects Maze's commitment to transparency and investor relations as they advance their precision medicine initiatives.

Market Sentiment Analysis

POSITIVE FACTORS

  • Maze Therapeutics is actively participating in investor conferences, indicating engagement with investors.
  • The presentation will showcase the company's progress in precision medicine development.
  • Exposure at industry conferences could enhance partnership opportunities for Maze.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with renal, metabolic and cardiovascular diseases, today announced that Jason Coloma, Ph.D., chief executive officer of Maze Therapeutics, will present a company overview and participate in one-on-one meetings at the 3rd Annual H.C. Wainwright BioConnect Investor Conference on Tuesday, May 20, 2025.
The presentation will be held at 11 a.m. ET and will be available in the Investors section of the company's website at mazetx.com. A replay of the presentation will be archived for 60 days.
If you would like to request a one-on-one meeting with company management during the conference, please reach out to your H.C. Wainwright representative.
About Maze Therapeutics
IR/Corporate Contact:
Amy Bachrodt, Maze Therapeutics
abachrodt@mazetx.com

Frequently Asked Questions

When will Maze Therapeutics present at the BioConnect Investor Conference?

Maze Therapeutics will present on May 20, 2025, at 11 a.m. ET.

Where can I watch the Maze Therapeutics presentation?

The presentation will be available in the Investors section of mazetx.com.

Will the Maze Therapeutics presentation be available later?

Yes, a replay will be archived for 60 days after the live presentation.

Who is presenting for Maze Therapeutics at the conference?

Jason Coloma, Ph.D., the CEO of Maze Therapeutics, will present.

How can I request a meeting with Maze Therapeutics management?

Contact your H.C. Wainwright representative to request a meeting.

Tags: MAZE Viatris Investor Conferences Healthcare Maze Therapeutics H.C. Wainwright BioConnect investor conference precision medicine
Last updated: May 13, 2025